MedPath
HSA Approval

NEOPAX FILM-COATED TABLET 400MG

SIN17065P

NEOPAX FILM-COATED TABLET 400MG

NEOPAX FILM-COATED TABLET 400MG

August 16, 2024

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L01EA01

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Krka-Farma d.o.o.

Active Ingredients

Imatinib mesylate eqv Imatinib

400mg

Imatinib

Documents

Package Inserts

1.4.3 Neopax Film-coated Tablets P I.pdf

Approved: August 16, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEOPAX FILM-COATED TABLET 400MG - HSA Approval | MedPath